Since the early 70s electrochemistry has been used as a powerful analytical technique for monitoring electroactive species in living organisms. In particular, after extremely rapid evolution of new micro and nanotechnology it has been established as an invaluable technique ranging from experiments in vivo to measurement of exocytosis during communication between cells under in vitro conditions. This review highlights recent advances in the development of electrochemical sensors for selective sensing of one of the most important neurotransmitters—dopamine. Dopamine is an electroactive catecholamine neurotransmitter, abundant in the mammalian central nervous system, affecting both cognitive and behavioral functions of living organisms. We have not attempted to cover a large time-span nor to be comprehensive in presenting the vast literature devoted to electrochemical dopamine sensing. Instead, we have focused on the last five years, describing recent progress as well as showing some problems and directions for future development.

Industrialization and the growing consumption of medicines leads to global aquatic contamination. One of the antibiotics widely used against bacterial infections in both human and veterinary medicine is tetracycline. Despite its positive antibiotic action, tetracycline is resistant against degradation, and therefore it accumulates in the environment, including the aquatic environment, creating great health hazards, possibly stimulating antibiotic resistance of pathogenic organisms. In this research, aqueous suspensions of semiconductor nanoparticles CdS were used for photocatalytic activity studies in the presence of methylene blue as a model compound, and finally, in the presence of tetracycline, a broad-spectrum antibiotic widely used against bacterial infections, as well as a live-stock food additive. The mechanism and kinetic rate constants of photocatalytic degradation processes of methylene blue and tetracycline were described in correlation with the energy diagram of CdS nanoparticles.

It has been proven and confirmed in numerous repeated tests, that the use of a combination of several therapeutic methods gives much better treatment results than in the case of separate therapies. Particularly promising is the combination of ionizing radiation and magnetic hyperthermia in one drug. To achieve this objective, magnetite nanoparticles have been modified in their core with α emitter ²²⁵Ac, in an amount affecting only slightly their magnetic properties. By 3-phosphonopropionic acid (CEPA) linker nanoparticles were conjugated covalently with trastuzumab (Herceptin^®), a monoclonal antibody that recognizes ovarian and breast cancer cells overexpressing the HER2 receptors. The synthesized bioconjugates were characterized by transmission electron microscopy (TEM), Dynamic Light Scattering (DLS) measurement, thermogravimetric analysis (TGA) and application of ¹³¹I-labeled trastuzumab for quantification of the bound biomolecule. The obtained results show that one ²²⁵Ac@Fe₃O₄-CEPA-trastuzumab bioconjugate contains an average of 8–11 molecules of trastuzumab. The labeled nanoparticles almost quantitatively retain ²²⁵Ac (>98%) in phosphate-buffered saline (PBS) and physiological salt, and more than 90% of ²²¹Fr and ²¹³Bi over 10 days. In human serum after 10 days, the fraction of ²²⁵Ac released from ²²⁵Ac@Fe₃O₄ was still less than 2%, but the retention of ²²¹Fr and ²¹³Bi decreased to 70%. The synthesized ²²⁵Ac@Fe₃O₄-CEPA-trastuzumab bioconjugates have shown a high cytotoxic effect toward SKOV-3 ovarian cancer cells expressing HER2 receptor in-vitro. The in-vivo studies indicate that this bioconjugate exhibits properties suitable for the treatment of cancer cells by intratumoral or post-resection injection. The intravenous injection of the ²²⁵Ac@Fe₃O₄-CEPA-trastuzumab radiobioconjugate is excluded due to its high accumulation in the liver, lungs and spleen. Additionally, the high value of a specific absorption rate (SAR) allows its use in a new very perspective combination of α radionuclide therapy with magnetic hyperthermia.

The challenges associated with the uncontrolled presence of antibiotics such as tetracycline in the environment have necessitated their removal through different techniques. Tetracycline is hard to degrade in living organisms and can even be converted to more toxic substances. In view of this, we synthesized iron oxide nanoparticles with good magnetization (70 emu g⁻¹) and 15 nm particle size for the adsorption and photocatalytic degradation of tetracycline. Characterization carried out on the synthesized iron oxides revealed a bandgap of 1.83 eV and an isoelectric point at pH 6.8. The results also showed that the pH of the solution does not directly influence the adsorption of tetracycline. The adsorption isotherm was consistent with the model proposed by Langmuir, having 97 mg g⁻¹ adsorption capacity. Combined with the superparamagnetic behavior, this capacity is advantageous for the magnetic extraction of tetracycline from wastewater. The mechanisms of adsorption were proposed to be hydrogen bonding and n-π interactions. Photocatalytic degradation studies showed that approximately 40% of tetracycline degraded within 60 min of irradiation time with UV/vis light. The kinetics of photodegradation of tetracycline followed the pseudo-first-order mechanism, proceeding through hydroxyl radicals generated under illumination. Moreover, the photogenerated hydrogen peroxide could lead to heterogeneous photo-Fenton processes on the surface of iron oxide nanoparticles, additionally generating hydroxyl and hydroperoxyl radicals and facilitating photodegradation of tetracycline.

The exceptional magnetic properties of superparamagnetic iron oxide nanoparticles (SPIONs) make them promising materials for biomedical applications like hyperthermia, drug targeting and imaging. Easy preparation of SPIONs with the controllable, well-defined properties is a key factor of their practical application. In this work, we report a simple synthesis of Ho-doped SPIONs by the co-precipitation route, with controlled size, shape and magnetic properties. To investigate the influence of the ions ratio on the nanoparticles’ properties, multiple techniques were used. Powder X-ray diffraction (PXRD) confirmed the crystallographic structure, indicating formation of an Fe₃O₄ core doped with holmium. In addition, transmission electron microscopy (TEM) confirmed the correlation of the crystallites’ shape and size with the experimental conditions, pointing to critical holmium content around 5% for the preparation of uniformly shaped grains, while larger holmium content leads to uniaxial growth with a prism shape. Studies of the magnetic behaviour of nanoparticles show that magnetization varies with changes in the initial Ho³⁺ ions percentage during precipitation, while below 5% of Ho in doped Fe₃O₄ is relatively stable and sufficient for biomedicine applications. The characterization of prepared nanoparticles suggests that co-precipitation is a simple and efficient technique for the synthesis of superparamagnetic, Ho-doped SPIONs for hyperthermia application.

Magnetoliposomes are promising candidates for the development of selective drug delivery systems in the treatment of cancer. Those nanosystems were tested as carriers of a strong chemotherapeutic agent, doxorubicin, which is used against breast cancer. Herein, the magnetic properties of hydrophobic iron oxide nanoparticles located exclusively in the lipid bilayer were used to release this drug from the magnetoliposomes. The cytotoxic activity of the nanostructures against the normal and cancer cell lines was determined on the basis of cells viability measurement after incubation with different concentrations of these nanomaterials. In the same way, the effectiveness of killing cancer cells in combination with exposure to magnetic field was also evaluated. These experiments confirmed that the nanostructures composed of liposomes and magnetic nanoparticles are not cytotoxic. However, magnetoliposomes loaded with doxorubicin were effective and selective in reducing the viability of human breast tumor cell lines. In this paper, we demonstrated the promising application of the studied magnetoliposomes as carriers of doxorubicin released under the influence of magnetic field in tumor cells.